Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 November 2004, Vol. 104, No. 9, pp. 2994-2995.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hellmig, S.
Right arrow Articles by Schreiber, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hellmig, S.
Right arrow Articles by Schreiber, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

CORRESPONDENCE

To the editor:

IL-1 gene cluster polymorphisms and development of primary gastric B-cell lymphoma in Helicobacter pylori infection

In addition to bacterial virulence factors, host immune response plays a pivotal role in the outcome of chronic Helicobacter pylori infection. The capacity of the host to mount an interleukin-1{beta} (IL-1{beta})-driven response is influenced by sequence variants in the IL-1/IL-1RN cluster.1

El-Omar et al2 were the first to report an association between IL-1B -31 and IL-1RN 2/2 of IL-1RN 86 variable number of tandem repeats (VNTRs) and the development of chronic hypochlorhydric response to H pylori and the risk of gastric cancer. In contrast, very little is known about germ-line mutations predisposing patients with chronic H pylori infection to develop gastric mucosa-associated lymphoid tissue (MALT) lymphoma.

Therefore, we read with great interest the report by Rollison et al3 in Blood about an association between the proinflammatory genotype IL-1RN 2/2 with gastric marginal zone lymphoma in a retrospective series of 66 cases from northern England.

We investigated the functional variants in the IL-1 cluster and their influence on the development of primary gastric B-cell lymphoma in 153 patients participating in an intention-to-treat prospective multicenter study of the German-Austrian-Lymphoma Study Group.4 Included as controls were 344 patients with H pylori infection undergoing upper gastrointestinal (GI) endoscopy when histology of 2 biopsies taken from the antrum and the corpus of the stomach excluded gastric lymphoma.

Of 153 patients with primary gastric B-cell lymphoma, 88 presented with low-grade (MALT) and 65 patients with high-grade lymphoma (Table 1). The allele frequencies in the control group match well with those previously reported in the literature.2 There were no significant associations found with the histological grade or stage of disease in single marker analysis. Of patients with disease stages E II to E IV, 20.6% were homozygous for IL-1B -31 allele C, compared to only 10.2% of patients with disease stage E I (Pearson {chi}2 P = .112, OR 2.27, CI 95% 0.81-6.46). IL-1{beta} +3954 CC was found in 9.4% of patients with disease stages E II to E IV, compared to 2.8% of patients with stage E I (Pearson {chi}2 P = .109, OR 3.57, CI 95% 0.69-18.72) (Table 2). Haplotype analysis of the IL-1 cluster and especially the proinflammatory haplotype IL-1{beta} -31 C/IL-1RN 2 did not show any significant associations with histological grade or disease progression (Table 3).


View this table:
[in this window]
[in a new window]
 
Table 1.. Characteristics of 153 patients with primary gastric B-cell lymphoma

 

View this table:
[in this window]
[in a new window]
 
Table 2.. Single-marker analysis

 

View this table:
[in this window]
[in a new window]
 
Table 3.. Haplotype analysis

 

In conclusion we could not confirm the results of Rollinson et al.3 One reason may be that Rollinson et al extracted DNA to investigate germ-line mutations from biopsy specimen and surgical blocks of lymphoma tissue and not from peripheral blood. A contamination with tumor material cannot be excluded. The admixture of somatic DNA may have obscured their analysis. To our knowledge, there is no mechanistic evidence so far that the proinflammatory effect of IL-1{beta} contributes to development of primary gastric B-cell lymphoma. In contrast, recombinant IL-1{beta} exerted a marked antilymphoma activity, reflected by significantly improved survival of treated mice after inoculation of BCL-1 cells.5 The genetic susceptibility of patients with chronic H pylori infection to develop primary gastric B-cell lymphoma, especially of the MALT-type, appears to remain unclear.

Stephan Hellmig, Steffen Vollenberg, Maria-Elisabeth Goebeler-Kolve, Wolfgang Fischbach, Jochen Hampe, Ulrich Robert Fölsch, and Stefan Schreiber

Correspondence: Stephan Hellmig, Klinik für Allgemeine Innere Medizin, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Schittenhelmstr. 12, 24105 Kiel, Germany; e-mail: s.hellmig{at}mucosa.de.

References

  1. Hwang IR, Kodama T, Kikuchi S, et al. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology. 2002;123: 1793-1803.[CrossRef][Medline] [Order article via Infotrieve]

  2. El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature. 2000;404: 398-402.[CrossRef][Medline] [Order article via Infotrieve]

  3. Rollinson S, Levene AP, Mensah FK, et al. Gastric marginal zone lymphoma is associated with polymorphisms in genes involved in inflammatory response and antioxidative capacity. Blood. 2003;102: 1007-1011.[Abstract/Free Full Text]

  4. Fischbach W, Dragosics B, Kolve-Goebeler ME, et al. Primary gastric B-cell lymphoma: results of a prospective multicenter study. The German-Austrian Gastrointestinal Lymphoma Study Group. Gastroenterology. 2000;119: 1191-1202.[CrossRef][Medline] [Order article via Infotrieve]

  5. Chelstrom LM, Finnegan D, Uckun FM. Treatment of BCL-1 murine B-cell leukemia with recombinant cytokines: comparative analysis of the anti-leukemic potential of interleukin 1 beta (IL-1 beta), interleukin 2 (IL-2), interleukin-6 (IL-6), tumor necrosis factor alpha (TNF alpha), granulocyte colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), and their combination. Leuk Lymphoma. 1992;7: 79-86.[Medline] [Order article via Infotrieve]

  6. Carbone PP, Kaplan HS, Musshoff K, et al. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 1971;31: 1860-1861.[Free Full Text]

  7. Musshoff K. [Clinical staging classification of non-Hodgkin's lymphomas (author's transl)]. Strahlentherapie. 1977;153: 218-221.[Medline] [Order article via Infotrieve]

  8. Radaszkiewicz T, Dragosics B, Bauer P. Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis. Gastroenterology. 1992;102: 1628-1638.[Medline] [Order article via Infotrieve]

  9. Krawczak M, Konecki DS, Schmidtke J, et al. Allelic association of the cystic fibrosis locus and two DNA markers, XV2c and KM19, in 55 German families. Hum Genet. 1988;80: 78-80.[CrossRef][Medline] [Order article via Infotrieve]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
JCOHome page
T.-Y. Cheng, J.-T. Lin, L.-T. Chen, C.-T. Shun, H.-P. Wang, M.-T. Lin, T.-E. Wang, A.-L. Cheng, and M.-S. Wu
Association of T-Cell Regulatory Gene Polymorphisms With Susceptibility to Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
J. Clin. Oncol., July 20, 2006; 24(21): 3483 - 3489.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hellmig, S.
Right arrow Articles by Schreiber, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hellmig, S.
Right arrow Articles by Schreiber, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2004 by American Society of Hematology         Online ISSN: 1528-0020